Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease

Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease

US Patent 8524230 · Granted Sep 3, 2013

Estimated economic value: $73,082,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

GP130 binding molecules and methods of use2025
IL10RA binding molecules and methods of use2025
IL12 receptor synthetic cytokines and methods of use2025
IL10RB binding molecules and encoding nucleic acids2025
IL2RB binding molecules and methods of use2025
Compositions and methods related to IL27 receptor binding2025
IL27RAlpha binding molecules and methods of use2024
IL10 receptor binding molecules and methods of use2024
IFNGR binding synthetic cytokines and methods of use2024
IL2RG binding molecules and methods of use2024
P116 antibodies2024
Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodi2024